Pseudo Time Pe Tablet, Film Coated
NDC Package 49483-234-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Pseudo Time Pe (phenylephrine hchloride) tablets is uses:  Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies and nasal congestion associated with sinsitisTemporarily relieves sinus congestion and pressure. This formulation utilizes a tablet, film coated delivery system. Marketed by Time Cap Laboratories, Inc., this product is identified by NDC 49483-234 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
49483-234-00
Package Description
100000 TABLET, FILM COATED in 1 CARTON
Product Code
49483-234
11-Digit Billing Format
49483023400
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pseudo Time Pe
Non-Proprietary Name
Phenylephrine Hchloride
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PHENYLEPHRINE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
Uses:  Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies and nasal congestion associated with sinsitisTemporarily relieves sinus congestion and pressure

Regulatory & Marketing

Labeler Name
Time Cap Laboratories, Inc.
Product Type
Human Otc Drug
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-14-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (49483-234). Click a package code to view its specific billing and regulatory data.

49483-234-18
18 TABLET, FILM COATED in 1 BLISTER PACK
49483-234-36
36 TABLET, FILM COATED in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49483-234-00 identifies a specific commercial package of 100000 tablet, film coated in 1 carton of Pseudo Time Pe, a human over the counter drug labeled by Time Cap Laboratories, Inc.. This tablet, film coated is formulated for oral use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Time Cap Laboratories, Inc. on May 14, 2012. The current certification is valid through December 31, 2026.

How is this Time Cap Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49483023400. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49483-234-00
11-Digit CMS (5-4-2)
49483-0234-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.